Anacor Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
03 Jun 2015	Form 3: Bell Graeme, Executive VP and CFO No securities owned
12 Sep 2014	Form 3: Wierenga Wendall, Director No securities owned
30 May 2014	Form 3: Leonard Keith R, Director No securities owned
29 Apr 2014	Form 3: Sullivan Ryan T, Sr. VP and General Counsel No securities owned
14 Apr 2014	Form 3: Rodriguez Carmen R, Snr VP Reg Afrs & Qual. Assur. Holds 6,000 shares of Common Stock
10 Mar 2014	Form 3: Ippolito Vincent P, EVP & Chief Commercial Officer Holds 72,000 shares of Common Stock
15 Mar 2013	Form 3: Zane Lee, VP, Clinical Dev & Interim CMO
15 Mar 2013	Form 3: Chanda Sanjay, VP & Interim Head of Drug Deve
01 Jun 2012	Form 3: Berns Paul L, Director Holds 0 shares of No securities are beneficially owned
22 Dec 2011	Form 3: Rho Ventures Iv Holdings Llc, 10% owner Holds 1,533,600 shares of Common Stock
04 Apr 2011	Form 3: Rieflin William Jl, Director No securities owned
02 Dec 2010	Form 3: Venrock Healthcare Capital Partners Lp, See footnote 2 and 3 others Holds 2,000,000 shares of Common Stock
24 Nov 2010	Form 3: Glaxosmithkline Plc, 10% owner Holds 1,771,374 shares of Common Stock, $0.001 par value
23 Nov 2010	Form 3: Aberdare Ventures II, L.p., 10% owner and 3 others
23 Nov 2010	Form 3: Care Capital Investments Ii Lp, 10% owner and 1 other
23 Nov 2010	Form 3: Leschly Mark, Director
23 Nov 2010	Form 3: Klingenstein Paul H, Director
23 Nov 2010	Form 3: Markham Richard J, Director
23 Nov 2010	Form 3: Shapiro Lucy, Director Holds 6,666 shares of Common Stock
23 Nov 2010	Form 3: Hong Zhi, Director Holds 0 shares of Common Stock

Comments